“A significant event”: CBD-based pharma drug Epidiolex presented to FDA for approval

http://www.thecannabist.co/2017/11/03/cbd-epidiolex-fda-nda-gw-pharmaceuticals-pharmaceutical-drug/91562/ GW Pharmaceuticals, a.k.a. Greenwich Biosciences, has submitted to the FDA a New Drug Application for Epidiolex, a cannabis-based epilepsy drug with CBD.

Show More

Brian Wroblewski

Brian Wroblewski has a passion for writing, travel, food and family. Since working in and around the cannabis industry since 2008, Brian brings a unique perspective to the cannabis journalism space. With a focus on emerging brands, moving the cannabis industry forward and an undeniable passion for truth in business and journalism, find some of Brian's posts across the web on digital marketing, cannabis and a variety of different topics.

Related Articles

Back to top button